Titlebook: Artificial Intelligence in PET/CT Oncologic Imaging; John A. Andreou,Paris A. Kosmidis,Athanasios D. Go Book 2022 The Editor(s) (if applic

Systemic

Involvement of Homeless Fathersch as PSMA labeled either with F-18 or Ga-68, by the “theranostic” potential of F-18 or Ga-68 PSMA imaging–Lu-177 PSMA treatment, by the introduction of new imaging modalities such as PET/MRI, as well as by the application of Artificial Intelligence (AI) algorithms in PET instrumentation, data acqui

陶醉

Liability

POINT

978-3-031-10092-5The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl

小蟲

Introduction: Artificial Intelligence (AI) Systems for Oncology,ral studies have shown the potential of artificial intelligence systems applied in this domain. A brief introduction to artificial intelligence diving into its applications in oncological imaging and challenges that hinder its use in clinical practice are described.

頑固

PET/CT in Brain Tumors: Current Artificial Intelligence Applications,in tumors, mainly gliomas and brain metastases. Particular emphasis has been given to radiomics, i.e., the Artificial Intelligence method of extracting significant quantitative information from images of PET with the aid of statistical analysis. The radiopharmaceuticals used for PET imaging of brain

anus928

深淵

PET-CT in Lung Cancer,value for patient’s management and prognosis. PET-CT is widely used in lung cancer because of its superiority, compared to other imaging modalities, in the detection of nodal and metastatic disease. PET-CT combines in one single method the detailed anatomic information provided by CT with the functi

parallelism

CONE